On Thursday, TrueCar Inc (NASDAQ:TRUE)’s shares inclined 2.99% to $6.89.
Consumers in the market for a premium sports car may want to consider buying this month as July yields the largest percentage discount off MSRP for the segment, according to TrueCar, Inc. (NASDAQ: TRUE), the negotiation-free car buying and selling mobile marketplace.
TrueCar’s analysis of the four most recent years of new vehicle transactional data indicates that July is the best month for deals on luxury sports cars, with an average discount of 6.9 percent off MSRP. Within the segment, BMW’s convertible Z4 roadster is accessible at a particularly appealing price and makes the month’s list of best savings on new vehicles, TrueCar finds.
The sporty Z4 this month is accessible for an average transaction price of $53,503, or 7.7 percent off of MSRP. Lexus is also promoting special financing this month on its RC 350 coupe, presently accessible with a 0.9 percent interest loan for 36 months.
TrueCar, Inc. operates as an Internet-based information, technology, and communication services company. The company operates its platform on the TrueCar Website and TrueCar mobile applications. It also customizes and operates its platform for its affinity group marketing partners, counting financial institutions, membership-based organizations, and employee buying programs for large enterprises.
Unum Group (NYSE:UNM)’s shares dropped -3.63% to $36.10.
Unum Group (UNM) continues to experience sturdy sales and premium income enhance in addition to stable risk performance across core business segments and the closed block. These in turn assisted the company to outperform the Zacks Consensus Estimate in the first quarter.
With respect to the earnings surprise trend, the Zacks Rank #3 (Hold) accident and health insurer delivered a positive surprise in three of the last four quarters, with an average beat of 1.17%.
Over the past few years, the company’s conservative pricing and reservation practices have contributed to its overall profitability. Unum estimates 2015 operating earnings to grow 2–5% from the 2014 level.
In addition, Unum Group anticipates solid persistency and sales improvement in existing client relationships to continue driving sales higher in Unum U.S.
Unum Group, together with its auxiliaries, provides group and individual disability insurance products in the United States and the United Kingdom. The company operates through three segments: Unum US, Unum UK, and Colonial Life. It provides group long-term and short-term disability, group life, accidental death and dismemberment, individual disability, supplemental and voluntary products, and group and individual long-term care insurance products, in addition to accident, sickness and disability products, life products, and cancer and critical illness products.
At the end of Thursday’s trade, Inotek Pharmaceuticals Corp (NASDAQ:ITEK)‘s shares dipped -15.31% to $13.39.
Inotek Pharmaceuticals Corporation (ITEK) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases, recently declared that $20,970,000 of its 5.0% Convertible Senior Notes due 2020 (the “2020 Notes”) maturing February 15, 2020 have been converted into shares of common stock of the Company. The 2020 Notes converted into about 3.86 million shares, counting about 3.33 million shares underlying the 2020 Notes and about 0.53 million shares issued following the interest make-whole provision, which the Company elected to settle in shares. As a result of these conversions, Inotek has $30,000 of its 2020 Notes outstanding.
Inotek Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for glaucoma. The company’s lead product candidate comprises Trabodenoson, an adenosine mimetic that has accomplished Phase II clinical trials for lowering IOP by restoring the eye’s natural pressure control mechanism, in addition to for optic neuropathy.
Ciena Corporation (NYSE:CIEN), ended its Thursday’s trading session with 0.97% gain, and closed at $25.10.
Validating the ability to guarantee continuous business operations during a major disruption or natural disaster, Ciena ® (CIEN) was recently awarded ISO 22301 certification for its International Business Continuity Administration System (BCMS). Designed to certify resilience in managing business disruptions and other unpredictable events, ISO 22301 stipulates demanding requirements for implementing, operating, maintaining and improving a business continuity administration systems (BCMS).
Ciena Corporation provides equipment, software, and services that support the transport, switching, aggregation, service delivery, and administration of voice, video, and data traffic on communications networks worldwide. The company’s Converged Packet Optical segment offers networking solutions optimized for the convergence of coherent optical transport, OTN switching, and packet switching. Its products comprise the 6500 Packet-Optical Platform, 5430 Reconfigurable Switching System, CoreDirector Multiservice Optical Switches, and OTN configuration for the 5410 Reconfigurable Switching System.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
